Pharmetheus Ab
Pharmetheus AB, a leading name in the biopharmaceutical industry, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 2012, the company has established itself as a pioneer in pharmacometrics, offering innovative solutions in model-informed drug development and regulatory submissions. Pharmetheus provides a unique blend of services, including population pharmacokinetics, pharmacodynamics, and quantitative systems pharmacology, which set them apart in the competitive landscape. Their commitment to advancing drug development processes has garnered recognition, positioning them as a trusted partner for pharmaceutical companies aiming to optimise their clinical trials and improve patient outcomes. With a focus on scientific excellence and collaboration, Pharmetheus continues to achieve significant milestones in the realm of drug development.
DitchCarbon Score
How does Pharmetheus Ab's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmetheus Ab's score of 26 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmetheus Ab's reported carbon emissions
Pharmetheus Ab, headquartered in Sweden (SE), currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of concrete data, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and setting ambitious climate goals. Pharmetheus Ab may be part of this broader industry trend, but specific details regarding their climate commitments or initiatives are not available at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmetheus Ab is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
